Topic · page 11 of 47
Lupus & antiphospholipid syndrome
Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric
Briefs in Lupus & antiphospholipid syndrome
Lupus
Lupus Sci Med
Lupus Sci Med
Lupus Sci Med
Semin Arthritis Rheum
Lupus
Clin Exp Rheumatol
Lupus Sci Med
Semin Arthritis Rheum
Lupus
Ann Rheum Dis
Rheumatology (Oxford)
Lupus
Rheumatology (Oxford)
Beyond the surface: soluble SIGLEC-1 as a clinically applicable type I IFN biomarker
Diagnostic or prognostic study
Rheumatology (Oxford)
Lupus Sci Med
Arthritis Res Ther
Lupus
J Rheumatol
Arthritis Care Res (Hoboken)
Polypharmacy in Adults With Systemic Lupus Erythematosus
Cross-sectional study
Lupus Sci Med
Lupus
Lupus
Survey-based assessment of skin care knowledge and accessibility barriers in lupus
Cross-sectional study
Lupus
Lupus
Choroidal thickness in active lupus nephritis
Case-control study
Lupus
Lupus
Lupus
Arthritis Res Ther
Lupus
RMD Open
Lupus
Ann Rheum Dis
Ann Rheum Dis
J Rheumatol
Arthritis Care Res (Hoboken)
Lupus Sci Med
Age-related patterns of organ damage impact on health-related quality of life in SLE
Cross-sectional study
RMD Open
RMD Open
Lupus Sci Med